| Q39395434 | A "schizophotonic" all-in-one nanoparticle coating for multiplexed SE(R)RS biomedical imaging |
| Q62603072 | A Versatile, Modular Platform for Multivalent Peptide Ligands Based on a Dendritic Wedge |
| Q36191332 | A novel EGFR-targeted gene delivery system based on complexes self-assembled by EGF, DNA, and activated PAMAM dendrimers |
| Q50235462 | A simple new competition assay for heparin binding in serum applied to multivalent PAMAM dendrimers |
| Q46639069 | Acellular reactivity of polymeric dendrimer nanoparticles as an indicator of oxidative stress in vitro |
| Q39140837 | Adamantane in Drug Delivery Systems and Surface Recognition. |
| Q33563098 | Amino acid-functionalized dendrimers with heterobifunctional chemoselective peripheral groups for drug delivery applications |
| Q59310037 | An efficient approach to synthesize glycerol dendrimers via thiol–yne “click” chemistry and their application in stabilization of gold nanoparticles with X-ray attenuation properties |
| Q40041714 | An efficient, non-viral dendritic vector for gene delivery in tissue engineering. |
| Q48654705 | An update on nanoparticle-based contrast agents in medical imaging |
| Q80189238 | Analysis of fullerene-based nanomaterial in serum matrix by CE |
| Q39738527 | Anionic linear-globular dendrimer-cis-platinum (II) conjugates promote cytotoxicity in vitro against different cancer cell lines |
| Q39750884 | Anionic linear-globular dendrimers: biocompatible hybrid materials with potential uses in nanomedicine. |
| Q33503674 | Antibacterial activity and cytotoxicity of PEGylated poly(amidoamine) dendrimers |
| Q57777277 | Antimicrobial activity of poly(propylene imine) dendrimers |
| Q38269436 | Antimicrobial polymers. |
| Q38035033 | Aptamer-dendrimer bioconjugate: a nanotool for therapeutics, diagnosis, and imaging |
| Q50624258 | Assessment of the developmental toxicity of nanoparticles in an ex vivo 3D model, the murine limb bud culture system. |
| Q30825112 | Asymmetric peptide dendrimers are effective linkers for antibody-mediated delivery of diverse payloads to b cells in vitro and in vivo |
| Q89691238 | Atomistic computer simulations on multi-loaded PAMAM dendrimers: a comparison of amine- and hydroxyl-terminated dendrimers |
| Q50092687 | Binding analysis of antioxidant polyphenols with PAMAM nanoparticles |
| Q42595950 | Binding properties of water-soluble carbosilane dendrimers. |
| Q38849743 | Biocompatibility and nanostructured materials: applications in nanomedicine |
| Q36988348 | Biodegradable, polymeric nanoparticle delivery systems for cancer therapy |
| Q37575433 | Biohybrid polymer capsules |
| Q38114136 | Biomaterials as novel penetration enhancers for transdermal and dermal drug delivery systems |
| Q37793942 | Biomedical applications of dendrimers: a tutorial |
| Q46323033 | Biophysical studies in polymer therapeutics: the interactions of anionic and cationic PAMAM dendrimers with lipid monolayers. |
| Q36936207 | COMPARATIVE PHARMACOKINETICS OF PAMAM-OH DENDRIMERS AND HPMA COPOLYMERS IN OVARIAN-TUMOR-BEARING MICE |
| Q27022017 | Can nanomedicines kill cancer stem cells? |
| Q37363420 | Cancer, chitosan nanoparticles and catalytic nucleic acids. |
| Q38761270 | Carboxyl-Terminated PAMAM-SN38 Conjugates: Synthesis, Characterization, and in Vitro Evaluation |
| Q41901324 | Cationic PAMAM dendrimers as pore-blocking binary toxin inhibitors. |
| Q28546466 | Cationic Polyamidoamine Dendrimers as Modulators of EGFR Signaling In Vitro and In Vivo |
| Q28391763 | Cationic nanoparticles directly bind angiotensin-converting enzyme 2 and induce acute lung injury in mice |
| Q37365453 | Cationic nanoparticles induce nanoscale disruption in living cell plasma membranes |
| Q54505838 | Changes in gene expression pattern of human primary macrophages induced by carbosilane dendrimer 2G-NN16. |
| Q37715004 | Chapter 9 - Nanoparticles influence pathophysiology of spinal cord injury and repair. |
| Q33627998 | Characterization of tumor microvascular structure and permeability: comparison between magnetic resonance imaging and intravital confocal imaging |
| Q33714628 | Characterizing the lateral friction of nanoparticles on on-chip integrated black lipid membranes |
| Q33734954 | Charge-reversal polyamidoamine dendrimer for cascade nuclear drug delivery. |
| Q47403170 | Charged dendrimers under the action of AC electric fields: breathing characteristics of molecular size, polarizations, and ion distributions |
| Q34047132 | Click hybridization of immune cells and polyamidoamine dendrimers |
| Q31141823 | Collagen cross linking agents: design and development of a multifunctional cross linker |
| Q37142739 | Combinatorial and rational approaches to polymer synthesis for medicine |
| Q36334384 | Comparative biodistribution of PAMAM dendrimers and HPMA copolymers in ovarian-tumor-bearing mice |
| Q39407940 | Comparison of generation 3 polyamidoamine dendrimer and generation 4 polypropylenimine dendrimer on drug loading, complex structure, release behavior, and cytotoxicity |
| Q39463221 | Comparison of polymeric siRNA nanocarriers in a murine LPS-activated macrophage cell line: gene silencing, toxicity and off-target gene expression |
| Q58575571 | Complex Polymeric Architectures Self-Assembling in Unimolecular Micelles: Preparation, Characterization and Drug Nanoencapsulation |
| Q45035342 | Conjugation to Poly(amidoamine) Dendrimers and Pulmonary Delivery Reduce Cardiac Accumulation and Enhance Antitumor Activity of Doxorubicin in Lung Metastasis. |
| Q35545342 | Conscripts of the infinite armada: systemic cancer therapy using nanomaterials. |
| Q57777287 | Cytotoxicity of PAMAM, PPI and maltose modified PPIdendrimers in Chinese hamster ovary (CHO) and human ovarian carcinoma (SKOV3) cells |
| Q39699408 | Degradation behavior and biocompatibility of PEG/PANI-derived polyurethane co-polymers |
| Q26828423 | Dendrimer advances for the central nervous system delivery of therapeutics |
| Q37731623 | Dendrimer brain uptake and targeted therapy for brain injury in a large animal model of hypothermic circulatory arrest |
| Q37486970 | Dendrimer nanocarriers as versatile vectors in gene delivery |
| Q84755402 | Dendrimer-Based Drug Delivery Systems for Brain Targeting |
| Q39697618 | Dendrimer-based macromolecular conjugate for the kidney-directed delivery of a multitargeted sunitinib analogue |
| Q38820422 | Dendrimer-based nanocarriers: a versatile platform for drug delivery |
| Q47352518 | Dendrimer-induced leukocyte procoagulant activity depends on particle size and surface charge |
| Q38755622 | Dendrimer-mediated approaches for the treatment of brain tumor. |
| Q55563721 | Dendrimeric systems and their applications in ocular drug delivery. |
| Q30820441 | Dendrimeric β-cyclodextrin/Gd(III) chelate supramolecular host-guest adducts as high-relaxivity MRI probes |
| Q41734074 | Dendrimers as Nanocarriers for Nucleic Acid and Drug Delivery in Cancer Therapy. |
| Q92255519 | Dendrimers as Pharmaceutical Excipients: Synthesis, Properties, Toxicity and Biomedical Applications |
| Q37644203 | Dendrimers as drug delivery vehicles: non-covalent interactions of bioactive compounds with dendrimers |
| Q38296086 | Dendrimers as nonviral vectors in dendritic cell-based immunotherapies against human immunodeficiency virus: steps toward their clinical evaluation. |
| Q53398783 | Dendrimers as synthetic gene vectors: cell membrane attachment. |
| Q37279284 | Dendrimers for enhanced drug solubilization. |
| Q38196447 | Dendrimers for gene delivery--a potential approach for ocular therapy? |
| Q57079937 | Dendrimers in RNAi Delivery |
| Q47333126 | Dendrimers in combination with natural products and analogues as anti-cancer agents |
| Q26825175 | Dendrimers in drug delivery and targeting: Drug-dendrimer interactions and toxicity issues |
| Q33820501 | Dendrimers: synthesis, applications, and properties |
| Q26746182 | Dendritic Polymers for Theranostics |
| Q57345057 | Dendritic poly(benzyl ether)-b -poly(N -vinylcaprolactam) block copolymers: Self-organization in aqueous media, thermoresponsiveness and biocompatibility |
| Q64928048 | Dental remineralization via poly(amido amine) and restorative materials containing calcium phosphate nanoparticles. |
| Q37728426 | Design and creativity in synthesis of multivalent neoglycoconjugates |
| Q37834336 | Design of biocompatible dendrimers for cancer diagnosis and therapy: current status and future perspectives |
| Q36119295 | Design of nanovectors for therapy and imaging of cardiovascular diseases |
| Q64117846 | Designing and Characterization of a Novel Delivery System for Improved Cellular Uptake by Brain Using Dendronised Apo-E-Derived Peptide |
| Q37823446 | Designing dendrimers for drug delivery and imaging: pharmacokinetic considerations |
| Q50921462 | Developmental toxicity of low generation PAMAM dendrimers in zebrafish. |
| Q48206008 | Dexamethasone - PAMAM dendrimer conjugates for retinal delivery: preparation, characterization and in vivo evaluation |
| Q44187225 | Diaminobutane (DAB) dendrimers are potent binders of oral phosphate |
| Q36052346 | Different patterns of nuclear and mitochondrial penetration by the G3 PAMAM dendrimer and its biotin-pyridoxal bioconjugate BC-PAMAM in normal and cancer cells in vitro |
| Q33806089 | Double targeting of tumours with pyrenyl-modified dendrimers encapsulated in an arene-ruthenium metallaprism. |
| Q24655744 | Drug delivery and nanoparticles:applications and hazards |
| Q42656489 | Drug delivery system based on dendritic nanoparticles for enhancement of intravesical instillation |
| Q40840204 | Ecotoxicity of nanoparticles |
| Q90353526 | Effect of 2nd and 3rd generation PAMAM dendrimers on proliferation, differentiation, and pro-inflammatory cytokines in human keratinocytes and fibroblasts |
| Q34666766 | Effect of Mass Transport in the Synthesis of Partially Acetylated Dendrimer: Implications for Functional Ligand-Nanoparticle Distributions |
| Q38940163 | Effect of methotrexate conjugated PAMAM dendrimers on the viability of MES-SA uterine cancer cells |
| Q33792946 | Effect of the Route of Administration and PEGylation of Poly(amidoamine) Dendrimers on Their Systemic and Lung Cellular Biodistribution |
| Q30578684 | Effect of the nanoparticle synthesis method on dendronized iron oxides as MRI contrast agents |
| Q59204649 | Effective dentinal tubule occlusion induced by polyhydroxy-terminated PAMAM dendrimer in vitro |
| Q38761757 | Effects of food-borne nanomaterials on gastrointestinal tissues and microbiota. |
| Q37345372 | Effects of nanomaterial physicochemical properties on in vivo toxicity. |
| Q38981740 | Efficient targeted gene delivery by a novel PAMAM/DNA dendriplex coated with hyaluronic acid. |
| Q47576847 | Electrostatic Self-Assembled Chitosan-Pectin Nano- and Microparticles for Insulin Delivery. |
| Q38724910 | Endocytic Uptake, Transport and Macromolecular Interactions of Anionic PAMAM Dendrimers within Lung Tissue |
| Q37990464 | Endocytosis at the nanoscale |
| Q58641789 | Enhanced Specificity in Capturing and Restraining Circulating Tumor Cells with Dual Antibody-Dendrimer Conjugates |
| Q34472589 | Enhanced bioactivity of internally functionalized cationic dendrimers with PEG cores |
| Q35020387 | Enhanced potency of nucleotide-dendrimer conjugates as agonists of the P2Y14 receptor: multivalent effect in G protein-coupled receptor recognition |
| Q38830847 | Enhancing MRI of liver metastases with a zwitterionized biodegradable dendritic contrast agent. |
| Q40158086 | Establishment of subcellular fractionation techniques to monitor the intracellular fate of polymer therapeutics II. Identification of endosomal and lysosomal compartments in HepG2 cells combining single-step subcellular fractionation with fluorescen |
| Q58869727 | Evaluation of a new dendrimeric structure as prospective drugs carrier for intravenous administration of antichagasic active compounds |
| Q30577158 | Evaluation of poly(amidoamine) dendrimers as potential carriers of iminodiacetic derivatives using solubility studies and 2D-NOESY NMR spectroscopy. |
| Q38764098 | Exploiting microRNAs As Cancer Therapeutics |
| Q38080724 | Exploiting the physicochemical properties of dendritic polymers for environmental and biological applications. |
| Q35059932 | Exploring cancer metastasis prevention strategy: interrupting adhesion of cancer cells to vascular endothelia of potential metastatic tissues by antibody-coated nanomaterial |
| Q34827321 | Exploring dendrimer towards dual drug delivery: pH responsive simultaneous drug-release kinetics. |
| Q34343876 | Exploring the efficiency of gallic acid-based dendrimers and their block copolymers with PEG as gene carriers. |
| Q33899121 | Fabrication, characterization and in vitro evaluation of poly(D,L-lactide-co-glycolide) microparticles loaded with polyamidoamine-plasmid DNA dendriplexes for applications in nonviral gene delivery |
| Q33686651 | Functional delivery of siRNA in mice using dendriworms |
| Q39626315 | G3.5 PAMAM dendrimers enhance transepithelial transport of SN38 while minimizing gastrointestinal toxicity. |
| Q57777308 | Genotoxicity of poly(propylene imine) dendrimers |
| Q58210360 | Gold: a versatile tool for in vivo imaging |
| Q37445335 | Heterogeneity in nanoparticles influences biodistribution and targeting |
| Q41762985 | Human relaxin gene expression delivered by bioreducible dendrimer polymer for post-infarct cardiac remodeling in rats |
| Q37450447 | Impact of Dendrimer Terminal Group Chemistry on Blockage of the Anthrax Toxin Channel: A Single Molecule Study |
| Q39339379 | Impact of Dendrimers on Solubility of Hydrophobic Drug Molecules |
| Q64970494 | In Silico and In Vitro Analysis of the 4,4',4''-((1,3,5-Triazine-2,4,6-triyl)tris(azanediyl))triphenol), an Antioxidant Agent with a Possible Anti-Inflammatory Function. |
| Q39038555 | In vitro cytotoxicity of the ternary PAMAM G3-pyridoxal-biotin bioconjugate |
| Q36373902 | In vivo molecular imaging using nanomaterials: general in vivo characteristics of nano-sized reagents and applications for cancer diagnosis |
| Q44205806 | In vivo toxicity evaluation of gold-dendrimer composite nanodevices with different surface charges |
| Q57777440 | In vivo toxicity of poly(propyleneimine) dendrimers |
| Q52812169 | Increased Active Tumor Targeting by An αvβ3-Targeting and Cell-Penetrating Bifunctional Peptide-Mediated Dendrimer-Based Conjugate. |
| Q37956522 | Influence of dendrimers on red blood cells. |
| Q36566183 | Injectable PAMAM dendrimer-PEG hydrogels for the treatment of genital infections: formulation and in vitro and in vivo evaluation |
| Q38074461 | Inspired by nature: fundamentals in nanotechnology design to overcome biological barriers. |
| Q38056690 | Interfacing engineered nanoparticles with biological systems: anticipating adverse nano-bio interactions |
| Q28391784 | Interplay of Oxidative Stress and Autophagy in PAMAM Dendrimers-Induced Neuronal Cell Death |
| Q57187420 | Intracellular macrophage uptake of rifampicin loaded mannosylated dendrimers |
| Q38075592 | Intravesical drug delivery for dysfunctional bladder |
| Q37787341 | Intravesical drug delivery: Challenges, current status, opportunities and novel strategies |
| Q64963029 | Introduction to Nanomedicine. |
| Q34529315 | Layer-by-layer supramolecular assemblies based on linear and star-shaped poly(glycerol methacrylate)s for doxorubicin delivery. |
| Q34539866 | Luminescence targeting and imaging using a nanoscale generation 3 dendrimer in an in vivo colorectal metastatic rat model. |
| Q39566386 | Mechanism of gene transfection by polyamidoamine (PAMAM) dendrimers modified with ornithine residues |
| Q34273356 | Mesoporous silica nanoparticles as a compound delivery system in zebrafish embryos |
| Q39139786 | MicroRNA therapeutics: towards a new era for the management of cancer and other diseases |
| Q90699667 | MicroRNAs and Long Non-coding RNAs in c-Met-Regulated Cancers |
| Q41372280 | Microfabricated particles for engineered drug therapies: elucidation into the mechanisms of cellular internalization of PRINT particles |
| Q39017196 | Microfluidic-assisted self-assembly of complex dendritic polyethylene drug delivery nanocapsules |
| Q26864738 | Modeling dendrimers charge interaction in solution: relevance in biosystems |
| Q30498368 | Modeling particle shape-dependent dynamics in nanomedicine |
| Q46544436 | Modification of the in vitro uptake mechanism and antioxidant levels in HaCaT cells and resultant changes to toxicity and oxidative stress of G4 and G6 poly(amidoamine) dendrimer nanoparticles |
| Q59134577 | Molecular Modeling to Study Dendrimers for Biomedical Applications |
| Q57517641 | Multifunctional Trackable Dendritic Scaffolds and Delivery Agents |
| Q36377061 | Multifunctional trackable dendritic scaffolds and delivery agents |
| Q39126802 | Nanobiomaterials' applications in neurodegenerative diseases |
| Q36687177 | Nanobiomaterials: a review of the existing science and technology, and new approaches |
| Q46181824 | Nanomedicine Faces Barriers. |
| Q38383478 | Nanomedicine for gene therapy. |
| Q28075999 | Nanomedicine in Central Nervous System (CNS) Disorders: A Present and Future Prospective |
| Q53638970 | Nanoparticle hardness controls the internalization pathway for drug delivery. |
| Q36809026 | Nanoparticle interaction with biological membranes: does nanotechnology present a Janus face? |
| Q57808219 | Nanoparticle-Mediated Combination Therapy: Two-in-One Approach for Cancer |
| Q33935474 | Nanoparticle-mediated systemic delivery of siRNA for treatment of cancers and viral infections |
| Q38785806 | Nanoparticles and radiotracers: advances toward radionanomedicine |
| Q93055994 | Nanoparticles applied to cancer immunoregulation |
| Q38067256 | Nanoparticles as drug delivery systems. |
| Q47707153 | Nanoparticles for Immune Cytokine TRAIL-Based Cancer Therapy. |
| Q36917908 | Nanoparticles in drug delivery and environmental exposure: same size, same risks? |
| Q37470319 | Nanoparticulate systems for growth factor delivery |
| Q58324579 | Nanoscale self-assembled multivalent (SAMul) heparin binders in highly competitive, biologically relevant, aqueous media |
| Q36807625 | Nanostructured materials for applications in drug delivery and tissue engineering |
| Q37668322 | Nanotechnology for bone materials |
| Q28390007 | Nanotoxicity: a key obstacle to clinical translation of siRNA-based nanomedicine |
| Q52597834 | Nanotoxicology: a personal perspective. |
| Q37058812 | Nanovehicular intracellular delivery systems |
| Q92431342 | Neuroligin-2-derived peptide-covered polyamidoamine-based (PAMAM) dendrimers enhance pancreatic β-cells' proliferation and functions |
| Q58617491 | New Advances in General Biomedical Applications of PAMAM Dendrimers |
| Q44460619 | New surface hydroxylated and internally quaternised poly(propylene imine) dendrimers as efficient biocompatible drug carriers of norfloxacin |
| Q36352418 | Nitric oxide-releasing dendrimers as antibacterial agents |
| Q38211725 | Nonviral gene delivery with dendritic self-assembling architectures |
| Q37805489 | Nonviral vectors for the delivery of small interfering RNAs to the CNS. |
| Q36829260 | Novel aldehyde-terminated dendrimers; synthesis and cytotoxicity assay |
| Q42125955 | Novel graft copolymers enhance in vitro delivery of antisense oligonucleotides in the presence of serum |
| Q41993264 | Novel monodisperse PEGtide dendrons: design, fabrication, and evaluation of mannose receptor-mediated macrophage targeting |
| Q37824425 | Novel technologies: A weapon against tuberculosis |
| Q43879817 | Novel wound sealants: biomaterials and applications. |
| Q90434725 | Nutraceuticals' Novel Formulations: The Good, the Bad, the Unknown and Patents Involved |
| Q33789970 | On the Possibility of Facilitated Diffusion of Dendrimers Along DNA. |
| Q38593380 | One-step Conjugation of Glycyrrhetinic Acid to Cationic Polymers for High-performance Gene Delivery to Cultured Liver Cell. |
| Q27691325 | Optical nano antennas: state of the art, scope and challenges as a biosensor along with human exposure to nano-toxicology |
| Q38382967 | Overcoming obstacles in microRNA delivery towards improved cancer therapy |
| Q38090586 | PAMAM dendrimer roles in gene delivery methods and stem cell research |
| Q34986138 | PAMAM nanoparticles promote acute lung injury by inducing autophagic cell death through the Akt-TSC2-mTOR signaling pathway |
| Q39754871 | PEGylated PAMAM dendrimers as a potential drug delivery carrier: in vitro and in vivo comparative evaluation of covalently conjugated drug and noncovalent drug inclusion complex |
| Q33507142 | PEGylated dendritic unimolecular micelles as versatile carriers for ligands of G protein-coupled receptors |
| Q38854493 | PEGylation of Polypropylenimine Dendrimer with Alkylcarboxylate Chain Linkage to Improve DNA Delivery and Cytotoxicity. |
| Q55449441 | PEGylation of polypropylenimine dendrimers: effects on cytotoxicity, DNA condensation, gene delivery and expression in cancer cells. |
| Q38736230 | Partially PEGylated PAMAM dendrimers as solubility enhancers of Silybin. |
| Q33740696 | Peptide and glycopeptide dendrimers and analogous dendrimeric structures and their biomedical applications. |
| Q35997103 | Peptide- and saccharide-conjugated dendrimers for targeted drug delivery: a concise review. |
| Q33874029 | Physicochemical and biological properties of self-assembled antisense/poly(amidoamine) dendrimer nanoparticles: the effect of dendrimer generation and charge ratio |
| Q37216165 | Poly(amidoamine) dendrimer-drug conjugates with disulfide linkages for intracellular drug delivery |
| Q30496206 | Poly(amidoamine) dendrimers on lipid bilayers I: Free energy and conformation of binding |
| Q43154774 | Poly(ethylene glycol) Corona Chain Length Controls End-Group-Dependent Cell Interactions of Dendron Micelles. |
| Q30664584 | Poly(ethylene oxide)-block-polyphosphoester-graft-paclitaxel conjugates with acid-labile linkages as a pH-sensitive and functional nanoscopic platform for paclitaxel delivery |
| Q58324580 | Polyglycerol-based amphiphilic dendrons as potential siRNA carriers for in vivo applications |
| Q36561667 | Polymer conjugates as anticancer nanomedicines |
| Q36648444 | Polymer therapeutics--polymers as drugs, drug and protein conjugates and gene delivery systems: past, present and future opportunities |
| Q36316919 | Polymeric carriers for gene delivery: chitosan and poly(amidoamine) dendrimers |
| Q38983708 | Polypeptide-Based Conjugates as Therapeutics: Opportunities and Challenges. |
| Q42917296 | Positively Charged Dendron Micelles Display Negligible Cellular Interactions |
| Q50528465 | Preparation and characterization of tablet formulation based on solid dispersion of glimepiride and poly(ester amide) hyperbranched polymer. |
| Q38918979 | Preparation methods and applications behind alginate-based particles |
| Q49520196 | Prevention of Synaptic Alterations and Neurotoxic Effects of PAMAM Dendrimers by Surface Functionalization |
| Q58324587 | Probing dendron structure and nanoscale self-assembly using computer-aided analysis of EPR spectra |
| Q33941477 | Properties and suspension stability of dendronized iron oxide nanoparticles for MRI applications. |
| Q37237705 | Radionuclide carriers for targeting of cancer |
| Q28085438 | Recent advances in dendrimer-based nanovectors for tumor-targeted drug and gene delivery |
| Q38556761 | Recent advances in targeted drug delivery approaches using dendritic polymers |
| Q37804383 | Receptor-targeted nanocarriers for therapeutic delivery to cancer |
| Q38947133 | Review on the targeted conjugation of anticancer drugs doxorubicin and tamoxifen with synthetic polymers for drug delivery |
| Q37380142 | Review: doxorubicin delivery systems based on chitosan for cancer therapy. |
| Q41710056 | Self-interrupted synthesis of sterically hindered aliphatic polyamide dendrimers. |
| Q37829181 | Shape-specific polymeric nanomedicine: emerging opportunities and challenges |
| Q36841577 | Size, charge and concentration dependent uptake of iron oxide particles by non-phagocytic cells |
| Q37259900 | Size-Dependent Endocytosis of Nanoparticles |
| Q42142803 | Solubility of aceclofenac in polyamidoamine dendrimer solutions |
| Q57366657 | Stable and pH-responsive polyamidoamine based unimolecular micelles capped with a zwitterionic polymer shell for anticancer drug delivery |
| Q38811573 | Structural dependence of in vitro cytotoxicity, oxidative stress and uptake mechanisms of poly(propylene imine) dendritic nanoparticles |
| Q40108825 | Studies on polyamidoamine dendrimers as efficient gene delivery vector |
| Q57079942 | Study of cationic carbosilane dendrimers as potential activating stimuli in macrophages |
| Q88735143 | Subconjunctival dendrimer-drug therapy for the treatment of dry eye in a rabbit model of induced autoimmune dacryoadenitis |
| Q46728997 | Surface Hydrophobic Modification of Fifth-Generation Hydroxyl-Terminated Poly(amidoamine) Dendrimers and Its Effect on Biocompatibility and Rheology. |
| Q38724798 | Surface charge and particle size determine the metabolic fate of dendritic polyglycerols |
| Q39214441 | Surface functionalisation regulates polyamidoamine dendrimer toxicity on blood-brain barrier cells and the modulation of key inflammatory receptors on microglia |
| Q37564495 | Surface modified poly(amido)amine dendrimers as diverse nanomolecules for biomedical applications |
| Q36988355 | Surface-active liposomes for targeted cancer therapy |
| Q35207056 | Synthesis and characterization of dendritic star-shaped zwitterionic polymers as novel anticancer drug delivery carriers |
| Q47205871 | Synthesis and evaluation of pegylated dendrimeric nanocarrier for pulmonary delivery of low molecular weight heparin |
| Q39958380 | Synthesis and in vitro characterization of a dendrimer-MORF conjugate for amplification pretargeting |
| Q60389765 | Synthesis of CpM(CO)3-DAB and -PAMAM Dendrimer Conjugates and Preliminary Evaluation of Their Biological Activity |
| Q42224830 | Synthesis of new anionic carbosilane dendrimers via thiol-ene chemistry and their antiviral behaviour |
| Q31119728 | Synthesis of surface-modified TREN-cored PAMAM dendrimers and their effects on the solubility of sulfamethoxazole (SMZ) as an analog antibiotic drug. |
| Q30564353 | Synthesis, structure and molecular modelling of anionic carbosilane dendrimers. |
| Q31161948 | Systematic investigation of polyamidoamine dendrimers surface-modified with poly(ethylene glycol) for drug delivery applications: synthesis, characterization, and evaluation of cytotoxicity. |
| Q37038825 | Targeted nanomaterials for radiotherapy |
| Q35525012 | Temperature-responsive biocompatible copolymers incorporating hyperbranched polyglycerols for adjustable functionality |
| Q57777403 | The biodistribution of maltotriose modified poly(propylene imine) (PPI) dendrimers conjugated with fluorescein-proofs of crossing blood-brain-barrier |
| Q37210936 | The delivery of therapeutic oligonucleotides |
| Q36954579 | The effect of particle design on cellular internalization pathways |
| Q38829707 | The evolution of gadolinium based contrast agents: from single-modality to multi-modality. |
| Q36128678 | The shape of things to come: importance of design in nanotechnology for drug delivery |
| Q38056805 | Theoretical and computational studies of dendrimers as delivery vectors. |
| Q38193333 | Theranostic nanoparticles for cancer and cardiovascular applications |
| Q39177093 | Towards understanding the distribution and tumor targeting of sericin regulated spherical calcium phosphate nanoparticles |
| Q37385444 | Toxicity of therapeutic nanoparticles |
| Q50002187 | Toxicology of Engineered Nanoparticles: Focus on Poly(amidoamine) Dendrimers |
| Q47870326 | Translocation across a self-healing block copolymer membrane. |
| Q39161020 | Trastuzumab labeled to high specific activity with ¹¹¹In by conjugation to G4 PAMAM dendrimers derivatized with multiple DTPA chelators exhibits increased cytotoxic potency on HER2-positive breast cancer cells. |
| Q47686179 | Two decades of dendrimers as versatile MRI agents: a tale with and without metals |
| Q92753241 | Unchain My Blood: Lessons Learned from Self-Assembled Dendrimers as Nanoscale Heparin Binders |
| Q33859472 | Use of Nanotechnology to Develop Multi-Drug Inhibitors For Cancer Therapy |
| Q57376851 | Use of multifunctional phosphorylated PAMAM dendrimers for dentin biomimetic remineralization and dentinal tubule occlusion |
| Q30413839 | Use of poly (amidoamine) dendrimer for dentinal tubule occlusion: a preliminary study |
| Q36508796 | Wnt11 plays an important role in the osteogenesis of human mesenchymal stem cells in a PHA/FN/ALG composite scaffold: possible treatment for infected bone defect |
| Q36823809 | Zwitterionic chitosan-polyamidoamine dendrimer complex nanoparticles as a pH-sensitive drug carrier |
| Q38622563 | pH-sensitive polymersomes: controlling swelling via copolymer structure and chemical composition. |